Arjun Agarwal

Senior Vice President, Finance · Oruka Therapeutics

Arjun Agarwal (Senior Vice President, Finance) filed 6 Form 4 reports in the trailing twelve months (0 purchases, 6 sales), most often in Oruka Therapeutics, Inc. (ORKA). The largest single filing was $1.1M of ORKA (10,000 sh across 5 lots, as filed), executed Aug 13. Data as of Nov 8 2026.

Add to watchlist

Return, ttmiAverage return per filing, trailing twelve months

–

no purchases on file

Delay-adjustediThe same average, entered at disclosure dates

–

returns measure stock purchases only

Filings, ttm

0 buys · 6 sells

Median delay

–

measured on stock purchases

Volume, ttmiDollar value disclosed in the trailing twelve months

$4.7M

shares × price, as filed

Last traded

Oct 12

Filed Oct 13

Median ADV $139.8M across their filed names

Open performance→

Volume by month

Buys $0 Sells $4.7M

Shares × price, as filed · by filing month · past 24 months

Sectors filed on

Healthcare 6 filings

Sector per market data · by filing · past 12 months

Most traded names

ORKA

Oruka Therapeutics, Inc. ORKA · 0 buys · 6 sells 6 filings

Recent filings

ORKASALE Oruka Therapeutics, Inc. View filing → $789K
9,799 sh across 3 lots
Exec Oct 12
Filed Oct 13 · 4:34 PM ET ORKASALE Oruka Therapeutics, Inc. View filing → $854K
9,259 sh across 3 lots
Exec Sep 11
Filed Sep 15 · 7:17 PM ET ORKASALE Oruka Therapeutics, Inc. View filing → $1.1M
10,000 sh across 5 lots
Exec Aug 13
Filed Aug 14 · 5:42 PM ET ORKASALE Oruka Therapeutics, Inc. View filing → $796K
9,399 sh across 2 lots
Exec Jul 13
Filed Jul 13 · 5:09 PM ET ORKASALE Oruka Therapeutics, Inc. View filing → $660K
9,459 sh across 3 lots
Exec Jun 12
Filed Jun 15 · 5:30 PM ET ORKASALE Oruka Therapeutics, Inc. View filing → $517K
8,790 sh across 2 lots
Exec May 18
Filed May 18 · 5:30 PM ET